financetom
Business
financetom
/
Business
/
Norwegian Cruise lifts profit forecast again after record ticket sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Norwegian Cruise lifts profit forecast again after record ticket sales
Nov 3, 2024 3:33 PM

(Reuters) - Norwegian Cruise Line Holdings ( NCLH ) on Thursday raised its annual profit forecast for a fourth time this year, encouraged by record third-quarter revenue and advance ticket sales.

Cruise operators marked robust demand this quarter for their vacation experiences as consumer spending in the U.S. increased at its fastest pace in 1-1/2 years and inflation slowed sharply.

Norwegian Cruise's quarterly revenue increased 11% year-over-year to a record $2.81 billion.

The Oceania Cruises operator said its advance ticket sales balance ended the third quarter at $3.3 billion, a quarterly record high and about 6% higher than the same period in 2023.

It now expects an adjusted profit of $1.65 per share for fiscal 2024, compared with its previous forecast of $1.53.

"Fueled by robust demand ... we're raising our full-year guidance for a fourth time and expect 2024 to be our best year for revenue," said CEO Harry Sommer.

Shares of the company, which have gained 19% this year, were up nearly 2% in premarket trading.

The company also raised its 2024 revenue-per-cruise-day forecast to about 9.4%, from its prior outlook of 8.2%, driven by demand across all three brands and itineraries in the second half of the year.

Rival Royal Caribbean also lifted its annual profit forecast on Tuesday for the fourth time this year, benefiting from robust demand.

(Reporting by Savyata Mishra in Bengaluru and Doyinsola Oladipo in New York; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New US tariffs could prompt Signify to move some production from China, CEO says
New US tariffs could prompt Signify to move some production from China, CEO says
Nov 3, 2024
AMSTERDAM (Reuters) - Lighting maker Signify is considering moving some of its production out of China if the company is confronted with a new round of U.S. tariffs, its chief executive said on Friday. Signify, the world's biggest maker of lights, is looking at production sites in India, Indonesia and changing existing operations in Mexico, CEO Eric Rondolat said on...
IDEAYA Biosciences Reports 'Positive' Interim Phase 1 Data for Cancer Drug; Shares Rise Pre-Bell
IDEAYA Biosciences Reports 'Positive' Interim Phase 1 Data for Cancer Drug; Shares Rise Pre-Bell
Nov 3, 2024
08:06 AM EDT, 10/25/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported positive interim expansion data Friday for IDE397 in patients with methylthioadenosine phosphorylase-deletion urothelial cancer and non-small cell lung cancer. The oncology company said that it observed a manageable safety profile with no drug-related serious adverse events or discontinuations at the 30mg once-a-day expansion dose. Shares of IDEAYA...
New US tariffs could prompt Signify to move some production from China, CEO says
New US tariffs could prompt Signify to move some production from China, CEO says
Nov 3, 2024
AMSTERDAM, Oct 25 (Reuters) - Lighting maker Signify is considering moving some of its production out of China if the company is confronted with a new round of U.S. tariffs, its chief executive said on Friday. Signify, the world's biggest maker of lights, is looking at production sites in India, Indonesia and changing existing operations in Mexico, CEO Eric Rondolat...
Market Chatter: AstraZeneca's Former Executives Under Investigation in China
Market Chatter: AstraZeneca's Former Executives Under Investigation in China
Nov 3, 2024
08:08 AM EDT, 10/25/2024 (MT Newswires) -- AstraZeneca's ( AZN ) former senior executive is being investigated by Chinese authorities, Bloomberg reported on Friday, citing local media outlets. The report said Eva Yin, currently the Chief Commercial Officer for Beigene, was recently detained. It added that Yin had worked at AstraZeneca ( AZN ) for over 15 years, including serving...
Copyright 2023-2025 - www.financetom.com All Rights Reserved